Abstract

Crimean-Congo hemorrhagic fever virus (CCHFV), a nairovirus, is a tick-borne zoonotic virus that causes hemorrhagic fever in humans. The CCHFV nucleoprotein (NP) is the antigen most used for serological screening of CCHFV infection in animals and humans. To gain insights into antibody epitopes on the NP molecule, we produced recombinant chimeric NPs between CCHFV and Nairobi sheep disease virus (NSDV), which is another nairovirus, and tested rabbit and mouse antisera/immune ascites, anti-NP monoclonal antibodies, and CCHFV-infected animal/human sera for their reactivities to the NP antigens. We found that the amino acids at positions 161–320 might include dominant epitopes recognized by anti-CCHFV IgG antibodies, whereas cross-reactivity between anti-CCHFV and anti-NSDV antibodies was limited. Their binding capacities were further tested using a series of synthetic peptides whose sequences were derived from CCHFV NP. IgG antibodies in CCHFV-infected monkeys and patients were reactive to some of the synthetic peptide antigens (e.g., amino acid residues at positions 131–150 and 211–230). Only a few peptides were recognized by IgG antibodies in the anti-NSDV serum. These results provide useful information to improve NP-based antibody detection assays as well as antigen detection tests relying on anti-NP monoclonal antibodies.

Highlights

  • Introduction distributed under the terms andCrimean-Congo hemorrhagic fever (CCHF) is an important tick-borne zoonotic disease with wide geographic distribution

  • All the chimeric proteins were expressed in the cells and antisera/Mouse Immune Ascites Fluids (MIAFs) and Crimean-Congo hemorrhagic fever virus (CCHFV)-infected monkey sera were tested for their reactivities to wildtype CCHFV NP, Nairobi sheep disease virus (NSDV) NP, and Ch-NPs in Western blotting (Table 1)

  • CCHFV NP epitopes have been mapped in previous studies [9,25,26,29], detailed information on the epitopes on orthonairoviruses is still needed

Read more

Summary

Introduction

Crimean-Congo hemorrhagic fever (CCHF) is an important tick-borne zoonotic disease with wide geographic distribution. Due to its high mortality rate and potential to cause an epidemic, it constitutes a public health threat [1,2]. There are no approved vaccines or antiviral drugs for CCHF [3]. In anticipation of a potential epidemic event, the conditions of the Creative Commons. WHO Blueprint ranks CCHF as one of the diseases necessitating research and development attention [4,5]. CCHF is caused by the CCHF virus (CCHFV), a member of the genus

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.